Showing results (1-10 of 40) with videos related to
Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|June 5, 2014
Correction of lysosomal dysfunction as a therapeutic strategy for neurodegenerative diseasesRobert E Boyd, Kenneth J ValenzanoMolecular Therapy : the Journal of the American Society of Gene Therapy|April 17, 2015
Pharmacological Chaperone Therapy: Preclinical Development, Clinical Translation, and Prospects for the Treatment of Lysosomal Storage DisordersGiancarlo Parenti, Generoso Andria, Kenneth J ValenzanoJournal of Medicinal Chemistry|November 15, 2002
Novel, potent ORL-1 receptor agonist peptides containing alpha-Helix-promoting conformational constraintsChongwu Zhang, Wendy Miller, Kenneth J Valenzano, et al.Bioorganic & Medicinal Chemistry Letters|September 3, 2003
Design and parallel synthesis of piperidine libraries targeting the nociceptin (N/OFQ) receptorZhengming Chen, Wendy S Miller, Shen Shan, et al.Bioorganic & Medicinal Chemistry Letters|February 26, 2004
Design and synthesis of novel small molecule N/OFQ receptor antagonistsZhengming Chen, R Richard Goehring, Kenneth J Valenzano, et al.Bioorganic & Medicinal Chemistry Letters|January 25, 2005
4-(2-Pyridyl)piperazine-1-benzimidazoles as potent TRPV1 antagonistsBin Shao, Jincheng Huang, Qun Sun, et al.The Journal of Biological Chemistry|April 30, 2002
Vasoactive intestinal polypeptide type-1 receptor regulation. Desensitization, phosphorylation, and sequestrationMichael A Shetzline, Julia K L Walker, Kenneth J Valenzano, et al.Bioorganic & Medicinal Chemistry Letters|September 30, 2004
Design and synthesis of 4-phenyl piperidine compounds targeting the mu receptorZhengming Chen, Ellen Davies, Wendy S Miller, et al.The Journal of Pharmacology and Experimental Therapeutics|May 2, 2003
N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: II. in vivo characterization in rat models of inflammatory and neuropathic painJames D Pomonis, James E Harrison, Lilly Mark, et al.Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Synthesis and evaluation of pyridazinylpiperazines as vanilloid receptor 1 antagonistsLaykea Tafesse, Qun Sun, Lori Schmid, et al.Pageof 4